ID   CDK16_HUMAN             Reviewed;         496 AA.
AC   Q00536; A8K280; B7Z7C8; J3KN74; J3KQP7;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   12-OCT-2022, entry version 209.
DE   RecName: Full=Cyclin-dependent kinase 16;
DE            EC=2.7.11.22;
DE   AltName: Full=Cell division protein kinase 16;
DE   AltName: Full=PCTAIRE-motif protein kinase 1;
DE   AltName: Full=Serine/threonine-protein kinase PCTAIRE-1;
GN   Name=CDK16; Synonyms=PCTAIRE1, PCTK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=1639063; DOI=10.1002/j.1460-2075.1992.tb05360.x;
RA   Meyerson M., Enders G.H., Wu C.-L., Su L.-K., Gorka C., Nelson C.,
RA   Harlow E., Tsai L.-H.;
RT   "A family of human cdc2-related protein kinases.";
RL   EMBO J. 11:2909-2917(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-78; SER-82; SER-95; SER-119
RP   AND SER-138, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138; SER-153 AND SER-155, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-42; SER-78; SER-82; SER-95;
RP   SER-119 AND SER-138, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119 AND SER-153, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   FUNCTION, CATALYTIC ACTIVITY, AND INTERACTION WITH CCNY.
RX   PubMed=22796189; DOI=10.1016/j.cellsig.2012.06.018;
RA   Shehata S.N., Hunter R.W., Ohta E., Peggie M.W., Lou H.J., Sicheri F.,
RA   Zeqiraj E., Turk B.E., Sakamoto K.;
RT   "Analysis of substrate specificity and cyclin Y binding of PCTAIRE-1
RT   kinase.";
RL   Cell. Signal. 24:2085-2094(2012).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH BRSK2, SUBCELLULAR LOCATION,
RP   MUTAGENESIS OF SER-12; SER-153 AND LYS-194, PHOSPHORYLATION AT SER-12, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=22798068; DOI=10.1074/jbc.m112.375618;
RA   Chen X.Y., Gu X.T., Saiyin H., Wan B., Zhang Y.J., Li J., Wang Y.L.,
RA   Gao R., Wang Y.F., Dong W.P., Najjar S.M., Zhang C.Y., Ding H.F., Liu J.O.,
RA   Yu L.;
RT   "Brain-selective kinase 2 (BRSK2) phosphorylation on PCTAIRE1 negatively
RT   regulates glucose-stimulated insulin secretion in pancreatic beta-cells.";
RL   J. Biol. Chem. 287:30368-30375(2012).
RN   [16]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, INTERACTION WITH CCNY,
RP   AND MUTAGENESIS OF SER-119; SER-153 AND LYS-194.
RX   PubMed=22184064; DOI=10.1128/mcb.06261-11;
RA   Mikolcevic P., Sigl R., Rauch V., Hess M.W., Pfaller K., Barisic M.,
RA   Pelliniemi L.J., Boesl M., Geley S.;
RT   "Cyclin-dependent kinase 16/PCTAIRE kinase 1 is activated by cyclin Y and
RT   is essential for spermatogenesis.";
RL   Mol. Cell. Biol. 32:868-879(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-65; SER-95; SER-138;
RP   SER-153 AND SER-155, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 163-478.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of the PCTAIRE1 kinase in complex with indirubin e804.";
RL   Submitted (JUN-2010) to the PDB data bank.
CC   -!- FUNCTION: Protein kinase that plays a role in vesicle-mediated
CC       transport processes and exocytosis. Regulates GH1 release by brain
CC       neurons. Phosphorylates NSF, and thereby regulates NSF oligomerization.
CC       Required for normal spermatogenesis. Regulates neuron differentiation
CC       and dendrite development (By similarity). Plays a role in the
CC       regulation of insulin secretion in response to changes in blood glucose
CC       levels. Can phosphorylate CCNY at 'Ser-336' (in vitro). {ECO:0000250,
CC       ECO:0000269|PubMed:22184064, ECO:0000269|PubMed:22796189,
CC       ECO:0000269|PubMed:22798068}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.22;
CC         Evidence={ECO:0000269|PubMed:22184064, ECO:0000269|PubMed:22796189,
CC         ECO:0000269|PubMed:22798068};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.22; Evidence={ECO:0000269|PubMed:22184064,
CC         ECO:0000269|PubMed:22796189, ECO:0000269|PubMed:22798068};
CC   -!- SUBUNIT: Found in a complex containing CABLES1, CDK17 and TDRD7.
CC       Interacts with YWHAH, YWHAQ and YWHAZ. Interacts with NSF. Identified
CC       in a complex with NSF, syntaxin-1, synaptotagmin, SYN1, SYP and CDK5R1
CC       (By similarity). Interacts with BRSK2. Interacts with CCNY; this
CC       increases the CDK16 kinase activity. {ECO:0000250,
CC       ECO:0000269|PubMed:22184064, ECO:0000269|PubMed:22796189,
CC       ECO:0000269|PubMed:22798068}.
CC   -!- INTERACTION:
CC       Q00536; Q92624: APPBP2; NbExp=3; IntAct=EBI-726261, EBI-743771;
CC       Q00536; Q8ND76-1: CCNY; NbExp=7; IntAct=EBI-726261, EBI-11615526;
CC       Q00536; Q8N7R7: CCNYL1; NbExp=4; IntAct=EBI-726261, EBI-10103094;
CC       Q00536; Q15436: SEC23A; NbExp=3; IntAct=EBI-726261, EBI-81088;
CC       Q00536; O43829: ZBTB14; NbExp=3; IntAct=EBI-726261, EBI-10176632;
CC       Q00536-3; P30281: CCND3; NbExp=3; IntAct=EBI-12401765, EBI-375013;
CC       Q00536-3; O43829: ZBTB14; NbExp=3; IntAct=EBI-12401765, EBI-10176632;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasmic vesicle, secretory
CC       vesicle. Cell membrane; Peripheral membrane protein; Cytoplasmic side.
CC       Synapse, synaptosome {ECO:0000250}. Note=Colocalizes with insulin in
CC       pancreas islets. Recruited to the cell membrane by CCNY.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q00536-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q00536-2; Sequence=VSP_046134;
CC       Name=3;
CC         IsoId=Q00536-3; Sequence=VSP_046342;
CC   -!- TISSUE SPECIFICITY: Detected in pancreas islets (at protein level).
CC       Detected in brain and pancreas. {ECO:0000269|PubMed:22798068}.
CC   -!- PTM: Phosphorylation at Ser-153 inhibits kinase activity.
CC       {ECO:0000269|PubMed:22798068}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH01048.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH15607.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X66363; CAA47006.1; -; mRNA.
DR   EMBL; BT006827; AAP35473.1; -; mRNA.
DR   EMBL; AK290145; BAF82834.1; -; mRNA.
DR   EMBL; AK301832; BAH13564.1; -; mRNA.
DR   EMBL; AL096791; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL513366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471164; EAW59295.1; -; Genomic_DNA.
DR   EMBL; CH471164; EAW59297.1; -; Genomic_DNA.
DR   EMBL; BC001048; AAH01048.1; ALT_INIT; mRNA.
DR   EMBL; BC015607; AAH15607.1; ALT_INIT; mRNA.
DR   CCDS; CCDS14276.1; -. [Q00536-1]
DR   CCDS; CCDS48101.1; -. [Q00536-3]
DR   CCDS; CCDS55408.1; -. [Q00536-2]
DR   PIR; S23385; S23385.
DR   RefSeq; NP_001163931.1; NM_001170460.1. [Q00536-2]
DR   RefSeq; NP_006192.1; NM_006201.4. [Q00536-1]
DR   RefSeq; NP_148978.2; NM_033018.3. [Q00536-3]
DR   RefSeq; XP_016885059.1; XM_017029570.1. [Q00536-1]
DR   RefSeq; XP_016885060.1; XM_017029571.1. [Q00536-1]
DR   RefSeq; XP_016885061.1; XM_017029572.1. [Q00536-1]
DR   RefSeq; XP_016885062.1; XM_017029573.1. [Q00536-1]
DR   PDB; 3MTL; X-ray; 2.40 A; A=163-478.
DR   PDB; 5G6V; X-ray; 2.20 A; A/B=163-478.
DR   PDBsum; 3MTL; -.
DR   PDBsum; 5G6V; -.
DR   AlphaFoldDB; Q00536; -.
DR   SMR; Q00536; -.
DR   BioGRID; 111154; 122.
DR   ComplexPortal; CPX-379; Cyclin Y-CDK16 complex.
DR   IntAct; Q00536; 49.
DR   MINT; Q00536; -.
DR   STRING; 9606.ENSP00000276052; -.
DR   BindingDB; Q00536; -.
DR   ChEMBL; CHEMBL4597; -.
DR   DrugBank; DB07766; (2Z,3E)-2,3'-biindole-2',3(1H,1'H)-dione 3-{O-[(3R)-3,4-dihydroxybutyl]oxime}.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q00536; -.
DR   GlyGen; Q00536; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q00536; -.
DR   PhosphoSitePlus; Q00536; -.
DR   BioMuta; CDK16; -.
DR   DMDM; 266425; -.
DR   EPD; Q00536; -.
DR   jPOST; Q00536; -.
DR   MassIVE; Q00536; -.
DR   MaxQB; Q00536; -.
DR   PaxDb; Q00536; -.
DR   PeptideAtlas; Q00536; -.
DR   PRIDE; Q00536; -.
DR   ProteomicsDB; 57854; -. [Q00536-1]
DR   Antibodypedia; 374; 235 antibodies from 30 providers.
DR   DNASU; 5127; -.
DR   Ensembl; ENST00000276052.10; ENSP00000276052.6; ENSG00000102225.17. [Q00536-2]
DR   Ensembl; ENST00000357227.9; ENSP00000349762.4; ENSG00000102225.17. [Q00536-1]
DR   Ensembl; ENST00000457458.6; ENSP00000405798.2; ENSG00000102225.17. [Q00536-3]
DR   Ensembl; ENST00000518022.5; ENSP00000429751.1; ENSG00000102225.17. [Q00536-1]
DR   GeneID; 5127; -.
DR   KEGG; hsa:5127; -.
DR   MANE-Select; ENST00000357227.9; ENSP00000349762.4; NM_006201.5; NP_006192.1.
DR   UCSC; uc004dho.4; human. [Q00536-1]
DR   CTD; 5127; -.
DR   DisGeNET; 5127; -.
DR   GeneCards; CDK16; -.
DR   HGNC; HGNC:8749; CDK16.
DR   HPA; ENSG00000102225; Tissue enhanced (skeletal).
DR   MIM; 311550; gene.
DR   neXtProt; NX_Q00536; -.
DR   OpenTargets; ENSG00000102225; -.
DR   PharmGKB; PA33095; -.
DR   VEuPathDB; HostDB:ENSG00000102225; -.
DR   eggNOG; KOG0594; Eukaryota.
DR   GeneTree; ENSGT00940000156963; -.
DR   InParanoid; Q00536; -.
DR   OrthoDB; 1010560at2759; -.
DR   PhylomeDB; Q00536; -.
DR   TreeFam; TF106508; -.
DR   BRENDA; 2.7.11.22; 2681.
DR   PathwayCommons; Q00536; -.
DR   SignaLink; Q00536; -.
DR   SIGNOR; Q00536; -.
DR   BioGRID-ORCS; 5127; 12 hits in 742 CRISPR screens.
DR   ChiTaRS; CDK16; human.
DR   GeneWiki; PCTK1; -.
DR   GenomeRNAi; 5127; -.
DR   Pharos; Q00536; Tchem.
DR   PRO; PR:Q00536; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q00536; protein.
DR   Bgee; ENSG00000102225; Expressed in right hemisphere of cerebellum and 193 other tissues.
DR   ExpressionAtlas; Q00536; baseline and differential.
DR   Genevisible; Q00536; HS.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0000307; C:cyclin-dependent protein kinase holoenzyme complex; IPI:ComplexPortal.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA.
DR   GO; GO:0043005; C:neuron projection; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0008021; C:synaptic vesicle; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006887; P:exocytosis; ISS:UniProtKB.
DR   GO; GO:0030252; P:growth hormone secretion; ISS:UniProtKB.
DR   GO; GO:0031175; P:neuron projection development; ISS:UniProtKB.
DR   GO; GO:0010508; P:positive regulation of autophagy; IDA:ComplexPortal.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   GO; GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:UniProtKB.
DR   GO; GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; IBA:GO_Central.
DR   GO; GO:0007283; P:spermatogenesis; ISS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell membrane; Cytoplasm;
KW   Cytoplasmic vesicle; Differentiation; Kinase; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Spermatogenesis; Synapse; Synaptosome; Transferase.
FT   CHAIN           1..496
FT                   /note="Cyclin-dependent kinase 16"
FT                   /id="PRO_0000086484"
FT   DOMAIN          165..446
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..97
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        81..96
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        286
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         171..179
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         194
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         12
FT                   /note="Phosphoserine; by BRSK2"
FT                   /evidence="ECO:0000269|PubMed:22798068,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         42
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195"
FT   MOD_RES         65
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         78
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195"
FT   MOD_RES         82
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195"
FT   MOD_RES         95
FT                   /note="Phosphoserine; by CDK5"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:23186163"
FT   MOD_RES         110
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q63686"
FT   MOD_RES         119
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:21406692"
FT   MOD_RES         138
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         153
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         155
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1
FT                   /note="M -> MPLYGRARDHVTHPSILGTRPGRPMAGPITAAVPEKICNGAFCSCSG
FT                   AFPLDPNNPSLGPLPSISHLNLRTQIAM (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046134"
FT   VAR_SEQ         1
FT                   /note="M -> MQSEIAM (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_046342"
FT   MUTAGEN         12
FT                   /note="S->A: Abolishes phosphorylation by BRSK2. Abolishes
FT                   effect on insulin secretion."
FT                   /evidence="ECO:0000269|PubMed:22798068"
FT   MUTAGEN         119
FT                   /note="S->A: Strongly reduces interaction with CCNY."
FT                   /evidence="ECO:0000269|PubMed:22184064"
FT   MUTAGEN         153
FT                   /note="S->A: Constitutively activated, due to loss of an
FT                   inhibitory phosphorylation site. Increases interaction with
FT                   CCNY."
FT                   /evidence="ECO:0000269|PubMed:22184064,
FT                   ECO:0000269|PubMed:22798068"
FT   MUTAGEN         153
FT                   /note="S->D: Abolishes interaction with CCNY."
FT                   /evidence="ECO:0000269|PubMed:22184064,
FT                   ECO:0000269|PubMed:22798068"
FT   MUTAGEN         194
FT                   /note="K->A: Loss of kinase activity. Abolishes effect on
FT                   insulin secretion."
FT                   /evidence="ECO:0000269|PubMed:22184064,
FT                   ECO:0000269|PubMed:22798068"
FT   MUTAGEN         194
FT                   /note="K->R: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:22184064,
FT                   ECO:0000269|PubMed:22798068"
FT   CONFLICT        25
FT                   /note="N -> D (in Ref. 3; BAH13564)"
FT                   /evidence="ECO:0000305"
FT   STRAND          165..173
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   STRAND          175..184
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   TURN            185..187
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   STRAND          190..197
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   HELIX           206..217
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   STRAND          226..231
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   STRAND          233..241
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   STRAND          244..246
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   HELIX           247..253
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   TURN            254..256
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   HELIX           260..279
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   STRAND          282..286
FT                   /evidence="ECO:0007829|PDB:3MTL"
FT   HELIX           289..291
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   STRAND          292..294
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   STRAND          300..302
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   STRAND          304..309
FT                   /evidence="ECO:0007829|PDB:3MTL"
FT   TURN            324..327
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   TURN            330..335
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   HELIX           342..357
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   HELIX           367..378
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   TURN            383..385
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   HELIX           389..391
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   HELIX           393..397
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   HELIX           408..411
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   HELIX           417..426
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   HELIX           431..433
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   HELIX           437..441
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   HELIX           444..449
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   HELIX           452..455
FT                   /evidence="ECO:0007829|PDB:5G6V"
FT   HELIX           462..465
FT                   /evidence="ECO:0007829|PDB:5G6V"
SQ   SEQUENCE   496 AA;  55716 MW;  9A5DDD34A5E5CBBB CRC64;
     MDRMKKIKRQ LSMTLRGGRG IDKTNGAPEQ IGLDESGGGG GSDPGEAPTR AAPGELRSAR
     GPLSSAPEIV HEDLKMGSDG ESDQASATSS DEVQSPVRVR MRNHPPRKIS TEDINKRLSL
     PADIRLPEGY LEKLTLNSPI FDKPLSRRLR RVSLSEIGFG KLETYIKLDK LGEGTYATVY
     KGKSKLTDNL VALKEIRLEH EEGAPCTAIR EVSLLKDLKH ANIVTLHDII HTEKSLTLVF
     EYLDKDLKQY LDDCGNIINM HNVKLFLFQL LRGLAYCHRQ KVLHRDLKPQ NLLINERGEL
     KLADFGLARA KSIPTKTYSN EVVTLWYRPP DILLGSTDYS TQIDMWGVGC IFYEMATGRP
     LFPGSTVEEQ LHFIFRILGT PTEETWPGIL SNEEFKTYNY PKYRAEALLS HAPRLDSDGA
     DLLTKLLQFE GRNRISAEDA MKHPFFLSLG ERIHKLPDTT SIFALKEIQL QKEASLRSSS
     MPDSGRPAFR VVDTEF
//
